ResearcherKyung Hee UniversityActive in the last 2 years

Yongmin Cho

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8361-9612; OpenAlex author ID A5019940084. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancreatic cancer cells. Co-author DOI 10.3389/fonc.2024.1442737 ↗
Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery. Co-author DOI 10.3390/nu13113801 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bonglee Kim · 2 shared papers, 2021–2024 · strength 0.32
- Paper Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancrea… DOI 10.3389/fonc.2024.1442737 ↗
- Paper Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery. DOI 10.3390/nu13113801 ↗
Md. Ataur Rahman · 1 shared paper, 2024 · strength 0.19
- Paper Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancrea… DOI 10.3389/fonc.2024.1442737 ↗
Moon Nyeo Park · 1 shared paper, 2024 · strength 0.19
- Paper Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancrea… DOI 10.3389/fonc.2024.1442737 ↗
Ahyeon Kim · 1 shared paper, 2021 · strength 0.13
- Paper Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery. DOI 10.3390/nu13113801 ↗
Seong‐Gyu Ko · 1 shared paper, 2021 · strength 0.13
- Paper Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery. DOI 10.3390/nu13113801 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.